Mumbai, the pharmaceutical hub , hosts several significant players in the Carboplatin Active Pharmaceutical Ingredient (API) creation landscape. Numerous firms , including Cipla, are known to manufacture Carboplatin API (CAS No: 41575-94-4) complying with stringent pharmaceutical standards. These reputable manufacturers cater to both local and glob